Lipopolysaccharide (LPS) is the principal proinflammatory component of the Gram-negative bacterial envelope (1). The lipopolysaccharide (LPS) receptor is a multi-protein complex that consists of at least three proteins, CD14, TLR4 and MD-2 (2). Each of these proteins are glycosylated. Specifically, MD-2 contains two N-linked glycosylation sites at positions Asn(26) and Asn(114) (2). MD-2 is indispensable for TLR4-dependent LPS responses because cells expressing TLR4/MD-2, but not TLR4 alone, respond to LPS (3). Intestinal epithelial cells (IEC) express low levels of TLR4 and MD-2 and are LPS unresponsive (4). T cell-derived cytokines lead to increased expression of TLR4 and MD-2, and LPS-dependent pro-inflammatory cytokine secretion in IEC (4). The human LY96 gene maps to chromosome 8q21.11 and encodes a 162 amino acid protein with a predicted 16-amino acid signal peptide (5,6).
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of MD-2 of human and, to a lesser extent, mouse and rat origin by WB, IP, IF and ELISA
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 1-160 representing full length MD-2 of human origin
Tissue Specificity
epitope corresponding to amino acids 1-160 representing full length MD-2 of human origin